Core Viewpoint - The company, Keres, has received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau, indicating violations in accounts receivable aging calculation, related party transaction disclosure, fundraising management, and insider information management [1] Group 1 - The Guangdong Securities Regulatory Bureau has mandated corrective measures for the company due to identified violations [1] - Regulatory measures include issuing warning letters to responsible individuals within the company [1]

Legal Issues - Danghong Technology is involved in a lawsuit with Guangxi Broadcasting Network Technology Development Co., Ltd., with a counterclaim amounting to RMB 35.9495 million, excluding legal fees and other costs [3] - Zhangjiajie faces a court ruling in a contract dispute with Zhuzhou CRRC Engineering, with the amount in question being RMB 20.144 million plus related penalties [12] Regulatory Actions - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [4] Business Developments - Dongfang Yuhong acquired mining rights for limestone in a bid worth RMB 267 million, valid from November 24, 2025, to November 24, 2045 [5] - Saikexide has received approval for three medical device products, enhancing its product range in the in vitro diagnostics sector [6] - Huayou Cobalt signed a supply agreement with Yiwei Lithium Energy for high-nickel ternary cathode materials, with an estimated supply of 127,800 tons from 2026 to 2035 [7] Stock Performance and Corporate Actions - Mengtian Home experienced a five-day stock price increase, with a total rise of 61.08%, significantly outpacing the Shanghai Composite Index [9] - Jiumuwang's stock showed abnormal fluctuations, with a revenue decline of 6.02% year-on-year for the first three quarters [10] - Huafeng shares are suspended due to a potential change in control, with a stock suspension expected to last no more than three trading days [11] - Baiyun Electric conducted its first share buyback, acquiring 86,500 shares for a total of RMB 1.0034 million [13] - Mercury Home Textiles plans to repurchase and cancel 137,200 restricted shares due to employee departures and performance issues [14] - Petty Co. announced a share buyback plan of RMB 50 million to 70 million, with a maximum price of RMB 26 per share [15] - Century Huatong obtained a loan commitment of up to RMB 900 million from China Merchants Bank for stock repurchase purposes [17] Shareholding Changes - Tongding Interconnection's major shareholder plans to reduce its stake by up to 0.49% [18] - Wanrun Co.'s controlling shareholder plans to increase its stake by no less than RMB 365 million and no more than RMB 730 million [19]

Core Viewpoint - The Shenzhen Stock Exchange issued a regulatory letter to Zhuhai Keres Technology Co., Ltd. highlighting multiple violations including improper accounts receivable aging calculations, failure to disclose related party transactions, irregularities in fundraising management, and inadequate insider information management [1][2][3] Group 1: Accounts Receivable Management - The company failed to continuously calculate the aging of accounts receivable after initial recognition and did not assess expected credit losses, leading to discontinuities in aging calculations [1] Group 2: Related Party Transaction Disclosure - There were three violations regarding related party transactions: - The company did not disclose the expected daily related party transactions for leasing a factory from a related party from May 2018 to December 2024, with the 2023 annual report lacking this disclosure until the 2024 report [2] - The 2023 annual report only disclosed transactions with Zhuhai Bojie Electronics Co., Ltd., omitting transactions with its subsidiaries and other related companies [2] - There was a discrepancy between the actual sales amount to Deyang Hongyi Electronics Co., Ltd. and the disclosed related party transaction amount [2] Group 3: Fundraising Management and Use - The company improperly managed fundraising for two projects, failing to allocate land purchase and construction costs according to building area, resulting in discrepancies in the reported progress of fundraising investment projects in multiple financial reports [2] Group 4: Insider Information Management - The company exhibited three major issues in insider information management: - The memorandum for significant matters only recorded the names of participating departments and external organizations, lacking details on personnel involved [3] - The insider information registries for the 2023 and 2024 annual reports were incomplete, missing key personnel [3] - There was a failure to timely document and manage insider information during the planning of equity incentive matters [3] Group 5: Regulatory Response - The Shenzhen Stock Exchange emphasized the need for the company and responsible individuals to take these issues seriously, learn from the mistakes, and implement timely rectifications to prevent recurrence of similar problems [3]

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Group 1 - Donghong Technology is involved in a lawsuit with a claim amounting to RMB 35.95 million, with some bank accounts frozen totaling RMB 30 million, and actual frozen funds of RMB 20.84 million [1] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Commission for violations related to accounts receivable aging calculation, related party transaction disclosure, fundraising management, and insider information management [2] - Oriental Yuhong successfully bid RMB 267 million for mining rights, valid from November 24, 2025, to November 24, 2045 [3] Group 2 - Saikexide has received approval for three medical device products, enhancing its product range and competitiveness in the in vitro diagnostics field [4] - Huayou Cobalt signed a supply agreement with Yiwei Lithium Energy for high-nickel ternary cathode materials, expected to supply approximately 127,800 tons from 2026 to 2035 [5] - Meng Tian Home's stock price has hit the limit for five consecutive trading days, with a total increase of 61.08%, significantly deviating from the Shanghai Composite Index's decline of 1.77% during the same period [6] Group 3 - Jiumuwang's stock experienced abnormal fluctuations, with a revenue decline of 6.02% year-on-year for the first three quarters of 2025, totaling RMB 633.13 million [7] - Huafeng Co. announced a continued suspension of trading due to a planned change in control, with the suspension expected to last no more than three trading days [8] - Zhangjiajie is involved in a court case with Zhuzhou CRRC Engineering, with a judgment amount of RMB 20.14 million, including penalties and related fees [9] Group 4 - Baiyun Electric conducted its first share buyback, acquiring 86,500 shares for a total of RMB 1.0034 million [11] - Mercury Home Textiles plans to repurchase and cancel 137,200 restricted shares due to the departure of two incentive targets and underperformance of five others [12] - Petty Co. approved a share buyback plan of RMB 50 million to 70 million, with a maximum price of RMB 26 per share, aimed at employee stock ownership plans [13] Group 5 - Century Huatong obtained a commitment letter from China Merchants Bank for a stock buyback loan of up to RMB 900 million, valid for 12 months [14] - Tongding Interconnection announced a major shareholder's plan to reduce holdings of up to 605,800 shares due to personal funding needs [15] - Wanrun Co.'s controlling shareholder plans to increase its stake in the company by investing between RMB 365 million and 730 million over the next six months [16]

Core Viewpoint - The company, Korys (301314.SZ), has received an administrative regulatory decision from the Guangdong Regulatory Bureau of the China Securities Regulatory Commission, indicating several violations related to financial reporting and management practices [1][2][3][4] Group 1: Accounts Receivable Management - The company failed to continuously calculate the aging of accounts receivable after switching to commercial acceptance bills for settlement, which does not comply with regulatory guidelines [1] Group 2: Related Party Transactions - The company did not properly disclose related party transactions, including a lease agreement with a related party that was not disclosed in the annual reports until 2024, violating disclosure regulations [2] - Incomplete disclosure of related party transactions with subsidiaries of Zhuhai Bojie Electronics Co., Ltd. was noted, along with inconsistencies in reported sales figures [2] Group 3: Fundraising Management - The company mismanaged the use of raised funds by not appropriately allocating costs between two fundraising projects, leading to discrepancies in reported project progress in multiple financial reports [3] Group 4: Insider Information Management - The company inadequately managed insider information, failing to record specific details about personnel involved in significant matters and not maintaining complete insider information registries in annual reports [4]

智通财经APP讯，科瑞思(301314.SZ)公告，公司近日收到中国证券监督管理委员会广东监管局出具《关 于对珠海科瑞思科技股份有限公司采取责令改正并对于志江、黄海亮、刘小民采取出具警示函措施的决 定》的行政监管措施决定书。决定书指出公司存在违规行为： (一)应收款项账龄计算不连续。公司在对某一客户应收账款初始确认后又转为商业承兑汇票结算，但未 连续计算账龄并评估预期信用损失。上述情形不符合《监管规则适用指引--发行类第5号》5-2条，《上 市公司信息披露管理办法》(证监会令第182号，下同)第三条第一款的规定。 (四)内幕信息知情人管理不规范。一是公司重大事项进程备忘录"参与机构和人员"相关信息中，只记载 了参与相关事项的内部部门以及外部机构名称，未记载参与人员姓名、职务、与上市公司关系等具体信 息。二是公司2023年、2024年年报内幕信息知情人登记不完整。三是公司筹划股权激励事项时，未及时 对相关工作进行书面记录并进行内幕信息知情人登记管理。上述情形不符合《上市公司监管指引第5号- -上市公司内幕信息知情人登记管理制度》(证监会公告〔2022〕17号)第六条第一款、第七条第一款及第 十条的规定。 (二) ...

科瑞思公告，公司收到广东证监局行政监管措施决定书，指出公司在应收款项账龄计算、关联交易披 露、募集资金管理和内幕信息管理方面存在违规行为。公司及相关责任人将严格按照要求进行整改，并 加强财务管理和内部控制。 ...

证券代码：301314 证券简称：科瑞思 公告编号：2025-038 珠海科瑞思科技股份有限公司 关于收到广东监管局对公司采取责令改正并对相关人员采取出 具警示函措施的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 经查，珠海科瑞思科技股份有限公司（以下简称科瑞思或公司）存在以下违 规行为： （一）应收款项账龄计算不连续。公司在对某一客户应收账款初始确认后又 转为商业承兑汇票结算，但未连续计算账龄并评估预期信用损失。上述情形不符 合《监管规则适用指引--发行类第 5 号》5-2 条，《上市公司信息披露管理办法》 （证监会令第 182 号，下同）第三条第一款的规定。 （二）未按规定审议披露关联交易。一是未审议披露关联交易。2018 年 5 月至2024年12月期间，公司连续承租关联方上高县卫玲电子科技有限公司厂房。 但公司在上市后审议日常关联交易预计的议案时未对该厂房租赁事项进行审议 披露，且在 2023 年年报中未披露该关联交易，2024 年年报中披露了该关联交易。 二是公司 2023 年年报披露了与珠海博杰电子股份有限公司（以下简称博杰股份） 关联交易 ...

证券代码：301314 证券简称：科瑞思 公告编号：2025-037 珠海科瑞思科技股份有限公司 关于离任监事持股及减持承诺事项的说明 本公司及董事会全体成员保证信息披露内容的真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为贯彻落实新修订的《中华人民共和国公司法》（以下简称"《公司法》"）， 按照中国证券监督管理委员会于 2025 年 3 月新修订颁布的《上市公司章程指引》 等规定，珠海科瑞思科技股份有限公司（以下简称"公司"）于 2025 年 10 月 27 日召开的第二届董事会第九次会议和第二届监事会第九次会议审议通过了 《关于取消监事会、调整公司组织架构并修订<公司章程>的议案》，于 2025 年 11 月 18 日召开的 2025 年第一次临时股东大会审议通过了《关于取消监事会、 调整公司组织架构并修订<公司章程>的议案》。 陈新裕先生担任监事会主席的原定任期到期日为 2026 年 11 月 15 日。截至 本公告日，陈新裕先生直接持有公司股份 3,319,550 股，占公司总股本的 6.01%， 通过珠海横琴瑞诺投资咨询企业（有限合伙）间接持有公司股份 102,708 股，占 总股本的 ...